27th February, 2025 In a major step towards making essential medicines more affordable, the National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical manufacturers and marketers to reduce the Maximum Retail Price (MRP) of specific drugs that recently received customs duty…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
